| Report on the Deliberation Results(Japanese only)Report on the Deliberation Results(Japanese only)Report on Investigation Results Date | Nonproprietary name | Information on revisions of PRECAUTIONS (from MHLW) |
Summary of investigation results (from PMDA) Reference article note) (if applicable) |
|---|---|---|---|
| August 28, 2026 |
|
PRECAUTIONS [144 KB] |
Summary of Investigation [75.3 KB] |
|
PRECAUTIONS [46.3 KB] |
Summary of Investigation [75.3 KB] |
|
| August 25, 2026 |
|
PRECAUTIONS [42.3 KB] |
Summary of Investigation [66.7 KB] |
|
PRECAUTIONS [47.3 KB] |
Report on Investigation Results [250 KB] Appendix 5 is not included in this file. See Detailed information on revisions of PRECAUTIONS. |
|
|
PRECAUTIONS [44.1 KB] |
Summary of Investigation Results[55.8 KB] (Appendix)[188 KB] Summary of the NBD study |
|
|
PRECAUTIONS [47.2 KB] |
Summary of Investigation Results[55.8 KB] (Appendix)[188 KB] Summary of the NBD study |
|
|
PRECAUTIONS [44.4 KB] |
Summary of Investigation [61.4 KB] |
|
|
PRECAUTIONS [37.5 KB] |
Summary of Investigation [51.7 KB] |
|
|
PRECAUTIONS [37.1 KB] |
Summary of Investigation [86.1 KB] |
|
|
PRECAUTIONS [36.9 KB] |
Summary of Investigation [54.4 KB] |
|
|
PRECAUTIONS [39.7 KB] |
Summary of Investigation [45.5 KB] |
|
|
PRECAUTIONS [45.2 KB] |
Summary of Investigation [61.4 KB] |
|
|
PRECAUTIONS [45.1 KB] |
Summary of Investigation [61.4 KB] |
|
|
PRECAUTIONS [47.6 KB] |
Summary of Investigation [43.2 KB] |
|
|
PRECAUTIONS [37.1 KB] |
Summary of Investigation [45.5 KB] |
|
|
PRECAUTIONS [34.8 KB] |
Summary of Investigation [28.9 KB] |
|
|
PRECAUTIONS [44.3 KB] |
Summary of Investigation [61.4 KB] |
|
|
PRECAUTIONS [42.8 KB] |
Summary of Investigation [61.4 KB] |
|
|
PRECAUTIONS [44.7 KB] |
Summary of Investigation [61.4 KB] |
|
|
PRECAUTIONS [42.1 KB] |
Summary of Investigation [61.4 KB] |
|
|
PRECAUTIONS [45.1 KB] |
Summary of Investigation [61.4 KB] |
|
|
PRECAUTIONS [41.3 KB] |
Summary of Investigation [61.4 KB] |
|
|
PRECAUTIONS [41.5 KB] |
Summary of Investigation [61.4 KB] |
|
|
PRECAUTIONS [41.8 KB] |
Summary of Investigation [61.4 KB] |
|
|
PRECAUTIONS [41.2 KB] |
Summary of Investigation [61.4 KB] |
|
|
PRECAUTIONS [41.2 KB] |
Summary of Investigation [61.4 KB] |
|
|
PRECAUTIONS [42.6 KB] |
Summary of Investigation [61.4 KB] |
|
|
PRECAUTIONS [52.3 KB] |
Summary of Investigation [48.7 KB] |
|
| August 24, 2026 |
|
PRECAUTIONS [77.8 KB] |
Review report for durvalumab (genetical recombination) [1,989 KB] (Japanese only) |
| August 17, 2026 |
|
PRECAUTIONS [51.1 KB] |
Summary of Investigation [38.4 KB] |
|
PRECAUTIONS [63.5 KB] |
Summary of Investigation [38.4 KB] |
|
| August 12, 2026 |
|
PRECAUTIONS [108 KB] |
Summary of Investigation [66.7 KB] |
| July 14, 2026 |
|
PRECAUTIONS [57.1 KB] |
Summary of Investigation [136 KB] |
|
PRECAUTIONS [57.8KB] |
Summary of Investigation [136 KB] |
|
|
PRECAUTIONS [103 KB] |
Summary of Investigation [99.4 KB] |
|
|
PRECAUTIONS [56KB] |
Summary of Investigation [136 KB] |
|
|
PRECAUTIONS [64.1 KB] |
Summary of Investigation [136 KB] |
|
|
PRECAUTIONS [134 KB] |
Summary of Investigation [128 KB] |
|
|
PRECAUTIONS [61.1 KB] |
Summary of Investigation [62.3 KB] |
|
|
PRECAUTIONS [61.5 KB] |
Summary of Investigation [95.6KB] |
|
|
PRECAUTIONS [60.9 KB] |
Summary of Investigation [54.4 KB] |
|
|
PRECAUTIONS [58.6 KB] |
Summary of Investigation [55.8 KB] |
|
|
PRECAUTIONS [60.5 KB] |
Summary of Investigation [62.3 KB] |
|
|
PRECAUTIONS [70.7 KB] |
Summary of Investigation [136 KB] |
|
|
PRECAUTIONS [110 KB] |
Summary of Investigation [103 KB] |
|
|
PRECAUTIONS [120 KB] |
Summary of Investigation [109KB] |
|
|
PRECAUTIONS [79.9KB] |
Summary of Investigation [30.3 KB] |
|
|
PRECAUTIONS [81.4 KB] |
Summary of Investigation [30.3 KB] |
|
|
PRECAUTIONS [80.9KB] |
Summary of Investigation [30.3 KB] |
|
| June 30, 2026 |
|
PRECAUTIONS [51.4 KB] |
Summary of Investigation [93.9 KB] |
|
PRECAUTIONS [51.3 KB] |
Summary of Investigation [93.9 KB] |
|
|
PRECAUTIONS [51.2 KB] |
Summary of Investigation [93.9 KB] |
|
|
PRECAUTIONS [51.3 KB] |
Summary of Investigation [93.9 KB] |
|
| June 16, 2026 |
|
PRECAUTIONS [65.4 KB] |
Report on Investigation [126 KB] |
|
PRECAUTIONS [58.1 KB] PRECAUTIONS [58.3 KB] |
Summary of Investigation [24.6 KB] |
|
|
PRECAUTIONS [138 KB] |
Summary of Investigation [43.5 KB] |
|
|
PRECAUTIONS [57.3 KB] PRECAUTIONS [57.2 KB] |
Summary of Investigation [35.1 KB] |
|
| June 5, 2026 |
|
PRECAUTIONS [43.3 KB] |
Summary of Investigation [71.2 KB] |
|
PRECAUTIONS [44.4 KB] |
Summary of Investigation [29.9 KB] |
|
| May 21, 2026 |
|
PRECAUTIONS [97 KB] |
Investigation [62 KB] Blue Letter [226 KB] |
| April 21, 2026 |
|
PRECAUTIONS [26.5KB] |
Summary of Investigation [73.8 KB] |
|
PRECAUTIONS [32.4 KB] |
Summary of Investigation [131 KB] |
|
|
PRECAUTIONS [31.4 KB] |
Summary of Investigation [131 KB] |
|
|
PRECAUTIONS [25.6 KB] |
Summary of Investigation [79.8 KB] |
|
|
PRECAUTIONS [25.6 KB] |
Summary of Investigation [78.6 KB] |
- Home
- Post-marketing Safety Measures
- Provision of Information Regarding Post-marketing Safety
- Drugs
- Revisions of PRECAUTIONS
- Revisions of PRECAUTIONS (FY2026)
Post-marketing Safety Measures